Modifications histologiques induites par les traitements conservateurs du cancer de la prostate et leurs conséquences sur l’interprétation du score de Gleason
Authors:
- Vincent MoliniéVMVincent Molinié
- W.K. MahjoubWMW.K. Mahjoub
- André BalatonABAndré Balaton
- 1 October 2008
- journal article
- abstracts
- Published by Elsevier in Annales de Pathologie
- Vol. 28 (5) , 363-373
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate CancerJournal of Urology, 2008
- Cancer mortality in the European Union, 1970–2003, with a joinpoint analysisAnnals of Oncology, 2008
- Early effects of pharmacological androgen deprivation in human prostate cancerBJU International, 2006
- Short‐term outcome after high‐intensity focused ultrasound in the treatment of patients with high‐risk prostate cancerBJU International, 2006
- Diagnostic utility of a p63/α‐methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsyBJU International, 2006
- EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCERJournal of Urology, 2004
- P63 and p504s cocktail is useful in ambiguous lesions of the prostateHistopathology, 2004
- Histological Changes of Minimally Invasive Procedures for the Treatment of Benign Prostatic Hyperplasia and Prostate Cancer: Clinical ImplicationsJournal of Urology, 2003
- A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasiaProstate Cancer and Prostatic Diseases, 1999
- Minimal or No Cancer in Radical Prostatectomy SpecimensAmerican Journal of Surgical Pathology, 1995